Quantinuum annonce la fixation du prix de son offre publique initiale majorée
Quantinuum Inc. has announced the pricing of its initial public offering (IPO) of 28,000,000 shares of its Class A common stock at a public offering price of $60.00 per share. The company has granted underwriters a 30-day option to purchase up to an additional 4,200,000 shares of Class A common stock to cover over-allotments at the IPO price, less underwriting discounts and commissions.
The Class A common stock is expected to begin trading on the Nasdaq Global Market on June 4, 2026, under the symbol “QNT.” The offering is expected to close on June 5, 2026, subject to customary closing conditions.
J.P. Morgan and Morgan Stanley are acting as joint book-running managers for the offering, while Jefferies and Evercore ISI are also serving as book-running managers. Additionally, BofA Securities, UBS Investment Bank, Cantor, Mizuho, Needham & Company, Société Générale, and TD Cowen are acting as joint book-running managers, with Craig-Hallum and Rosenblatt as co-managers.
A registration statement relating to this offering was declared effective by the Securities and Exchange Commission on June 3, 2026. The offering is available only by means of a prospectus. Copies of the prospectus, when available, may be obtained from J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Jefferies LLC, and Evercore Group L.L.C.
This announcement does not constitute an offer to sell or the solicitation of an offer to purchase these securities, and there will be no sale of these securities in any state or jurisdiction where such an offer, solicitation, or sale would be illegal prior to registration or qualification under the securities laws of any such state or jurisdiction.
Quantinuum is a leading quantum computing company that offers a comprehensive platform designed to enable quantum computing deployment in real-world environments. The company has commercially deployed multiple generations of quantum systems based on the well-established QCCD architecture, implemented with new designs and capabilities to achieve the highest levels of precision in the industry based on average two-qubit gate fidelity as of December 31, 2025. Quantinuum has active engagements with market leaders in pharmaceuticals, materials science, financial services, and governmental and industrial markets. The company is headquartered in Broomfield, Colorado, and has additional facilities in the United States, the United Kingdom, Germany, Japan, Qatar, and Singapore.